FIUME, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 1567
EU - Europa 992
AS - Asia 340
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 3002
Nazione #
US - Stati Uniti d'America 1566
GB - Regno Unito 362
CN - Cina 150
IT - Italia 133
SE - Svezia 123
UA - Ucraina 123
VN - Vietnam 110
DE - Germania 94
IN - India 68
TG - Togo 56
FR - Francia 50
RU - Federazione Russa 41
EE - Estonia 25
ZA - Sudafrica 22
BE - Belgio 14
SC - Seychelles 12
NG - Nigeria 10
HR - Croazia 8
GR - Grecia 4
JP - Giappone 4
RO - Romania 3
ES - Italia 2
FI - Finlandia 2
IR - Iran 2
NL - Olanda 2
PT - Portogallo 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
LB - Libano 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 3002
Città #
Southend 317
Fairfield 240
Chandler 198
Woodbridge 141
Ashburn 136
Wilmington 128
Houston 111
Seattle 109
Ann Arbor 106
Jacksonville 81
Princeton 68
Cambridge 67
Lomé 56
Bologna 41
Dong Ket 33
Padova 31
Westminster 30
Nanjing 21
Berlin 20
Shenyang 17
Saint Petersburg 15
Brussels 14
Jinan 14
Nanchang 13
Beijing 12
Mahé 12
Boardman 11
Abeokuta 10
San Diego 10
Changsha 9
Falls Church 9
Hangzhou 8
Redwood City 8
Hebei 7
Jiaxing 7
Tianjin 7
Haikou 6
Redmond 6
Dearborn 5
Sant'agata De' Goti 5
Verona 5
Zhengzhou 5
Des Moines 4
Kunming 4
Medford 4
Milan 4
Rijeka 4
Taiyuan 4
Taizhou 4
Hefei 3
Kuban 3
San Venanzo 3
Tokyo 3
Costa Mesa 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Moscow 2
North Bergen 2
Orange 2
Paris 2
Pont-Canavese 2
Aragona 1
Bremen 1
Cergy 1
Citta Sant'angelo 1
Cupertino 1
Delhi 1
Den Haag 1
Duino 1
Fuzhou 1
Genzano Di Roma 1
Groningen 1
Hanover 1
Istanbul 1
Kashan 1
Kuala Lumpur 1
Lanzhou 1
Lausanne 1
London 1
Los Angeles 1
Madrid 1
Milton Keynes 1
Monmouth Junction 1
Montevarchi 1
Mumbai 1
Napoli 1
Norwalk 1
Pavullo Nel Frignano 1
Phoenix 1
Quzhou 1
Riyadh 1
San Jose 1
Singapore 1
Stockholm 1
São Paulo 1
Tallinn 1
Turin 1
Vergato 1
Willowdale 1
Totale 2245
Nome #
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. 156
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 150
Liver targeted doxorubicin: effects on rat regenerating hepatocytes. 138
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 126
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 121
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 120
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 110
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 109
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin 107
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 106
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 105
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 105
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 104
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 103
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 102
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 102
Uso di coniugati della doxorubicina con albumina lattosaminata 98
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 98
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 94
Albumin-drug conjugates in the treatment of hepatic disorders. 92
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 89
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 89
Procedura per la preparazione di coniugati della doxorubicina con l’albumina umana lattosaminata 85
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. 84
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis 81
null 78
null 71
Lactosaminated human albumin: a hepatotropic carrier of drugs. 71
Process for the preparation of doxorubicin conjugates with lactosaminated human albumin 70
Use of conjugates of doxorubicin with lactosaminated albumin. 67
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 18
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 15
Totale 3064
Categoria #
all - tutte 4337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201859 0000 00 00 00590
2018/2019298 1130239 731 1811 29385032
2019/20201046 120281956 114116 129151 135665260
2020/2021518 120342529 2226 1323 573028111
2021/2022634 77145155 5229 2936 234512895
2022/2023473 811433389 5258 170 0000
Totale 3064